Pluri (PLUR) Cash & Equivalents (2010 - 2026)
Pluri (PLUR) recorded Cash & Equivalents of $3.53 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 40.1% from $5.9 million a year earlier.
Powered by 
Analysis
Pluri (PLUR) Cash & Equivalents (2010 - 2026) Analysis & Trends
Starting with fiscal Q1 2011, Pluri's Cash & Equivalents history includes 62 quarters.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -35.6% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $5.9 million in FY2025 (-13.1%), $6.78 million in FY2024 (+8.4%), $6.26 million in FY2023 (-45.2%) and $11.41 million in FY2022 (-64.2%).
- The fiscal Q4 2026 figure is the lowest quarterly Cash & Equivalents since fiscal Q1 2025.
- On a year-over-year basis, Cash & Equivalents rose in three of the last seven quarters, with an average decline of 10.9%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 145.7% in fiscal Q2 2022, against a decline of 81.6% in fiscal Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Pluri | 11.15 Mn | -1.62 Mn | - | 3.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.53 Mn |
| Dec 31, 2025 | 4.69 Mn |
| Sep 30, 2025 | 4.26 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 7.23 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 6.78 Mn |
| Mar 31, 2024 | 7.99 Mn |
| Dec 31, 2023 | 6.49 Mn |
| Sep 30, 2023 | 5.25 Mn |
| Jun 30, 2023 | 6.26 Mn |
| Mar 31, 2023 | 4.58 Mn |
| Dec 31, 2022 | 10.17 Mn |
| Sep 30, 2022 | 10.03 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Mar 31, 2022 | 24.93 Mn |
| Dec 31, 2021 | 19.22 Mn |
| Sep 30, 2021 | 15.22 Mn |
| Jun 30, 2021 | 31.84 Mn |
API Access
Pluri Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PLUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();